0
Education, Teaching, and Quality Improvement |

Retrospective Evaluation of the Pulmonary Embolism Rule-Out Criteria Rule at an Urban Academic Hospital

Andrew Bozarth, MD; Navin Bajaj, MD; Margaret Wessling, MD; Dustin Keffer, DO; Shais Jallu, MD; Gary Salzman, MD
Author and Funding Information

University of Missouri-Kansas City, School of Medicine, Kansas City, MO


Chest. 2013;144(4_MeetingAbstracts):569A. doi:10.1378/chest.1703839
Text Size: A A A
Published online

Abstract

SESSION TITLE: Patient Safety

SESSION TYPE: Original Investigation Slide

PRESENTED ON: Tuesday, October 29, 2013 at 02:45 PM - 04:15 PM

PURPOSE: The pulmonary embolism rule-out criteria (PERC) is an eight-variable clinical prediction model that identifies patients at low risk for pulmonary embolism (PE) in order to prevent unnecessary diagnostic testing in the evaluation of suspected PE in the emergency department (ED). The objective of this study was to determine PERC’s safety and diagnostic utility in our institution’s ED population.

METHODS: We performed a retrospective analysis on consecutive patients evaluated with computed tomography angiography (CTA) for suspicion of PE at our institution’s ED during the dates 1/1/2011 to 12/31/2011. Patients negative for all eight PERC criteria [i.e., “PERC (-)”] were considered to be at very low risk for PE, independent of physician gestalt. All data was analyzed using SPSS (version 20.0) in order to calculate the variables of interest and their respective 95% confidence intervals (95% CI).

RESULTS: During the 12-month study period, 729 subjects were evaluated with CTA for suspicion of PE. The prevalence of PE was 4.5%. Ten subjects were excluded because of non-diagnostic imaging studies (e.g., malfunction of the CT scanner or inappropriate timing of contrast). After exclusion, 719 subjects were available for analysis. Subjects’ mean age was 47 years (SD +/- 13, range 18-87). Females represented 61% of the population. Sixty-two percent were African-American, 32% White, and 6% other (self-identified). When PERC (-) is used as an independent diagnostic test to exclude the presence of PE, it had a sensitivity of 96.9% (95% CI, 84.3-99.4%), NPV of 98.7% (95% CI, 93.4-99.8%), and negative LR of 0.262 (95% CI, 0.014-1.544).

CONCLUSIONS: Use of PERC could have safely avoided 11.5% of CTAs, reducing potential patient harm, healthcare costs, and unnecessary diagnostic testing. Consistent with prior studies, PERC can be safely used to identify low risk patients for whom further testing can be deferred.

CLINICAL IMPLICATIONS: This simple bedside tool can be used with confidence (<2% false negative rate) in patients with a low pre-test probability for PE, thereby reducing unnecessary testing.

DISCLOSURE: The following authors have nothing to disclose: Andrew Bozarth, Navin Bajaj, Margaret Wessling, Dustin Keffer, Shais Jallu, Gary Salzman

No Product/Research Disclosure Information


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543